Ochs Law Firm Blog

Xarelto: New Isn’t Always Safer

xarelto lawyer If one were to watch or read an advertisement for Xarelto, one would likely think it perfectly safe to use for various medical applications. These would include:

  • Blood thinning, including clotting prevention
  • Stroke prevention
  • Systemic and pulmonary embolism prevention
  • Deep vein thrombosis prevention

Xarelto is manufactured by Jenssen Pharmaceuticals, a subsidiary of Johnson & Johnson, and Bayer Health.

Yet, the drug’s primary use is for blood thinning, and there are still many issues associated with this function. Blood thinners make it difficult for the body to clot in the event of a large wound, so one would, if using a blood thinner, continue to bleed until they ran out of blood.

Competitors, such as Warfarin, remedy this potentially fatal flaw by recommending the administering of vitamin K to the effected patient. However, there are no antidotes like this for Xarelto. This means that if a user suffers an injury where they would lose a great deal of blood, they have an increased likelihood of death.

Ironically, Xarelto launched a massive marketing campaign where it stated that it was a superior alternative to Warfarin and other well-known anticoagulants.

Apart from this gruesome error, Xarelto has been linked to the following potentially deadly side effects:

  • Stroke
  • GI tract bleeding
  • Hemorrhaging

Most other blood thinners require that the user take periodic blood tests to make sure that the drug is working like it should be. This is not the case with Xarelto, which is contributing factor to the abundance of the aforementioned effects.

The FDA was alerted to this very important fault. Since then, Xarelto’s producers have added warnings regarding these deadly potential side effects and its issues with thinning blood, but there remains concern that the manufacturers have failed to do any additional testing and have continued advertising the drug.

Many lawsuits versus Jenssen and Bayer are already under way. There are approximately 18,000 lawsuits pending in federal and state courts around the country. Two of these cases, Walsh v. Janssen Research & Development LLC et al and Roman v. Janssen Research & Development LLC et al., have both been won in the manufacturers’ favor in the Supreme Court of the State of New York, New York County. Both suits contended that Bayer and Jenssen hid their knowledge of the blood thinning issues due to a lack of clinical trials. Both Walsh and Roman claim that they suffered “life-threatening” bleeding as a result of taking Xarelto.

Another, similar drug, Pradaxa, is facing similar scrutiny for similar reasons, such as their marketing campaign stating Pradaxa is better than its competitors. Boehringer Ingelheim, the manufacturer, has already paid out $650 million in settlements.

Litigation is fully expected to continue against these “newer” anticoagulants.

Share Article



Our experienced Wyoming personal injury lawyer, Jason E. Ochs will fight to help you recover proper compensation in a class action, pharmaceutical, and medical cases throughout multiple states. Contact us today.

Jason E. Ochs

Jason began his legal career in 2002 with a national multi-district litigation law firm in Newport Beach, California. There he worked on a variety of high-profile, complex-litigation projects including pharmaceutical and medical-device litigation across the country.

The Ochs Law Firm epitomizes professionalism and commitment to all of our clients, regardless of the size of the case or the might of the Defendant. We practice in Wyoming, Colorado, Kansas and California in personal injury litigation, medical malpractice, defective products, class action lawsuits, Qui Tam lawsuits, litigation across multiple districts, bad faith insurance, and civil litigation.

We look forward to providing top quality service and representation for you and your family.